Press Releases Herantis Pharma Oyj

Equities

HRTIS

FI4000087861

Market Closed - Nasdaq Helsinki Other stock markets 07:46:37 2024-04-26 am EDT			5-day change	1st Jan Change
1.46 ^EUR	+2.10%		+1.74%	-7.30%

Mar. 06	Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle	Jan. 26	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s extraordinary general meeting of shareholders November 17, 2023	Nov. 16	PU
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders November 17, 2023	Nov. 15	PU
Herantis Pharma Plc's shares subscribed with option rights	23-07-19	AQ
Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096	23-07-04	AQ
Herantis Pharma Oyj: Managers' Transactions - Aki Prihti	23-06-20	AQ
Herantis Pharma Oyj: Managers' Transactions - Timo Veromaa	23-06-20	AQ
Herantis Pharma Oyj: Managers' Transactions - Frans Wuite	23-06-20	AQ
Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle	23-06-09	AQ
Herantis Pharma Oyj: Managers' Transactions - Antti Vuolanto	23-06-09	AQ
Herantis Pharma Oyj: Managers' Transactions - Henri Huttunen	23-06-09	AQ
Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel	23-06-02	AQ
Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day	23-05-22	PU
Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023	23-05-02	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s Annual General Meeting of shareholders 2023	23-04-26	PU
Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders	23-04-20	AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s Annual General Meeting of shareholders 2023	23-04-19	PU
Herantis Pharma announces first healthy volunteer dosed in the Phase 1a clinical study for the Parkinson's disease drug candidate, HER-096	23-04-19	AQ
Herantis Pharma Oyj : has signed European Innovation Council (EIC) Accelerator grant agreement	23-04-12	PU
Herantis Pharma to participate in Nordic Health Summit Japan 2023	23-04-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Herantis Pharma Oyj

Equities

HRTIS

FI4000087861

Press Releases

Filters